osaühing NURME APTEEK

10046931

General info

Name

osaühing NURME APTEEK

Registry code

10046931

VAT number

EE100403727

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

20.06.1996 (28)

Financial year

01.01-31.12

Capital

2 556.00 €

Activity

47731 - Dispensing chemist in specialised stores

Revenue

3 145 993 €

Profit

188 666 €

Profit margin

6%

Gross salary

2 173 €

(estimate is approximate)

Equity

211 555 €

Employees

8

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

89%

Return on assets

38%

Related parties

Owner Representative Beneficial owner Roles

Tiiu Vaha

16.11.1965 (58)

51% - 1 304.00 EUR Board member (chairman) Direct ownership

Arvo Kallasmaa

17.09.1961 (63)

49% - 1 252.00 EUR Board member Direct ownership

Financial info

2019
31.10.2020
2020
18.06.2021
2021
30.06.2022
2022
28.06.2023
2023
24.06.2024
Total Revenue 2 597 930 € 2 773 104 € 2 962 739 € 2 993 411 € 3 145 993 €
Net profit (loss) for the period 207 986 € 298 229 € 217 729 € 219 414 € 188 666 €
Profit Margin 8% 11% 7% 7% 6%
Current Assets 573 946 € 661 071 € 700 404 € 517 618 € 503 102 €
Fixed Assets 12 988 € 4 343 € 204 € 0 € 0 €
Total Assets 586 934 € 665 414 € 700 608 € 517 618 € 503 102 €
Current Liabilities 149 416 € 79 668 € 97 133 € 94 729 € 291 547 €
Non Current Liabilities 0 € 0 € 0 € 0 € 0 €
Total Liabilities - - - - -
Share Capital - - - - -
Equity 437 518 € 585 746 € 603 475 € 422 889 € 211 555 €
Employees 11 10 10 9 8

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 852 251.25 € 49 475.56 € 33 327.78 € 13
2023 Q4 891 292.03 € 136 291.3 € 41 128.34 € 12
2023 Q3 834 237.46 € 35 983.88 € 22 606.69 € 12
2023 Q2 802 608.28 € 37 541.33 € 23 618.73 € 11
2023 Q1 790 911.82 € 42 264.5 € 26 545.24 € 12
2022 Q4 859 436.71 € 135 663.89 € 36 415.36 € 12
2022 Q3 779 685.62 € 35 009.01 € 22 098.97 € 12
2022 Q2 758 058.56 € 37 487.5 € 21 922.05 € 12
2022 Q1 766 878.73 € 92 957.24 € 37 719.19 € 12
2021 Q4 877 710.68 € 50 000.22 € 26 315.98 € 12
2021 Q3 811 306.27 € 44 393 € 30 100.82 € 12
2021 Q2 706 668.12 € 31 160.59 € 18 587.7 € 13
2021 Q1 742 821.9 € 77 217.65 € 29 724.71 € 12
2020 Q4 783 441.95 € 34 276.89 € 17 644.28 € 11
2020 Q3 703 779.48 € 37 985.12 € 20 728.95 € 11
2020 Q2 777 080.26 € 37 906.59 € 18 677.57 € 11
2020 Q1 707 606.98 € 116 985.19 € 24 387.26 € 12